~~<i id='675EA319C1'><strike id='675EA319C1'><tt id='675EA319C1'><pre id='675EA319C1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：comprehensive 2025-10-01 10:56:44 - browse：92

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

focus

hotspot

focus

Wikipedia

hotspot

HealthandHumanServicesSecretaryXavierBecerratestifiesThursdayduringaSenateFinanceCommitteehearingonP

WSS

Pushing for an NIH office for post

China dismisses criticism of top diplomat's comments appearing to push for race

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Readout Newsletter: CAR

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Why scientists need input from humanists on sensitive research

hotspot

leisure time

focus

Walensky prepares to leave CDC — and Congress — behind

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

New air purifier tech could be key to improving indoor air quality

The leaders of Italy and Poland say European Union should focus on stopping migration

United colonoscopy coverage change 'may cost lives,' doctors say

Following judge's order, DOJ releases slightly less

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Search warrant issued in 1996 disappearance of Kristin Smart

focus

How many hemophilia patients actually want gene therapy?

The leaders of Italy and Poland say European Union should focus on stopping migration

Change Healthcare outage fallout shows need for new oversight

Ebola: Gilead Sciences antiviral shows promise as new treatment

Why scientists need input from humanists on sensitive research

Princess Kate attends Wimbledon with Roger Federer: See the photos

hotspot

focus

Wikipedia

hotspot